Thus, we assumed that FGF21 deletion might further elevate plasma glucose and triglyceride levels, contributing to the accelerated and aggravated development of DCM in FGF21KO diabetic mice. The gene discussed is FGF21; the disease is familial dilated cardiomyopathy.